AgomAb Therapeutics NV (AGMB)
NASDAQ: AGMB · Real-Time Price · USD
10.61
-0.03 (-0.28%)
Apr 29, 2026, 9:33 AM EDT - Market open
AgomAb Therapeutics NV Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Cash & Equivalents | 86.42 | 171.46 | 122.4 | 27.67 | 7.33 | Upgrade
|
| Short-Term Investments | 30.1 | - | - | 40 | - | Upgrade
|
| Cash & Short-Term Investments | 116.51 | 171.46 | 122.4 | 67.67 | 7.33 | Upgrade
|
| Cash Growth | -32.05% | 40.08% | 80.88% | 823.60% | 2155.87% | Upgrade
|
| Other Receivables | - | 2.12 | 16.95 | 3.33 | 0.16 | Upgrade
|
| Receivables | - | 2.12 | 16.95 | 3.33 | 0.16 | Upgrade
|
| Other Current Assets | 4.72 | 0.27 | 0.12 | 0.09 | - | Upgrade
|
| Total Current Assets | 121.24 | 173.85 | 139.47 | 71.09 | 7.48 | Upgrade
|
| Property, Plant & Equipment | 1.59 | 1.99 | 1.61 | 0.06 | - | Upgrade
|
| Goodwill | 8.61 | 8.61 | 8.61 | 8.61 | - | Upgrade
|
| Other Intangible Assets | 20.11 | 20.11 | 20.11 | 20.11 | - | Upgrade
|
| Other Long-Term Assets | 2.16 | 1.8 | 1.46 | 1.13 | - | Upgrade
|
| Total Assets | 153.71 | 206.36 | 171.26 | 101 | 7.48 | Upgrade
|
| Accounts Payable | 10.27 | 5.95 | 6.83 | 3.9 | - | Upgrade
|
| Accrued Expenses | - | 2.1 | 1.47 | 0.7 | - | Upgrade
|
| Current Portion of Leases | 0.25 | 0.27 | 0.18 | 0.03 | - | Upgrade
|
| Current Unearned Revenue | 1.55 | 0.8 | 1.18 | 1.78 | - | Upgrade
|
| Other Current Liabilities | 6.53 | - | 1.23 | 23.32 | - | Upgrade
|
| Total Current Liabilities | 18.59 | 9.13 | 10.89 | 29.72 | - | Upgrade
|
| Long-Term Leases | 1.01 | 1.27 | 1.44 | 0.04 | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | 0.62 | - | Upgrade
|
| Other Long-Term Liabilities | 3.21 | 7.88 | 7.5 | 4.37 | 0.86 | Upgrade
|
| Total Liabilities | 22.8 | 18.28 | 19.82 | 34.75 | 0.86 | Upgrade
|
| Common Stock | 223.07 | 0.03 | 0.03 | 0.03 | 10.18 | Upgrade
|
| Additional Paid-In Capital | 76.63 | - | - | - | - | Upgrade
|
| Retained Earnings | -181.71 | -119.1 | -72.83 | -61.44 | -3.56 | Upgrade
|
| Comprehensive Income & Other | 12.91 | 7.47 | 6.62 | 4.91 | - | Upgrade
|
| Total Common Equity | 130.9 | -111.6 | -66.19 | -56.51 | 6.62 | Upgrade
|
| Shareholders' Equity | 130.9 | 188.08 | 151.44 | 66.25 | 6.62 | Upgrade
|
| Total Liabilities & Equity | 153.71 | 206.36 | 171.26 | 101 | 7.48 | Upgrade
|
| Total Debt | 1.25 | 1.55 | 1.62 | 0.06 | - | Upgrade
|
| Net Cash (Debt) | 115.26 | 169.91 | 120.78 | 67.61 | 7.33 | Upgrade
|
| Net Cash Growth | -32.17% | 40.68% | 78.65% | 822.76% | 5771.49% | Upgrade
|
| Net Cash Per Share | 213.00 | 6796.56 | 4831.28 | 2704.32 | - | Upgrade
|
| Filing Date Shares Outstanding | 2.09 | 0.03 | 0.03 | 0.03 | - | Upgrade
|
| Total Common Shares Outstanding | 2.09 | 0.03 | 0.03 | 0.03 | - | Upgrade
|
| Working Capital | 102.65 | 164.72 | 128.59 | 41.37 | 7.48 | Upgrade
|
| Book Value Per Share | 62.65 | -4464.00 | -2647.64 | -2260.28 | - | Upgrade
|
| Tangible Book Value | 102.18 | -140.32 | -94.91 | -85.23 | 6.62 | Upgrade
|
| Tangible Book Value Per Share | 48.90 | -5612.88 | -3796.52 | -3409.16 | - | Upgrade
|
| Machinery | - | 0.32 | - | - | - | Upgrade
|
| Leasehold Improvements | - | 0.36 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.